Eduardo R. Fukutani

Eduardo R. Fukutani

Auto-generated profile, based on publicly available information

Eduardo R. Fukutani

The Biological Immunology & Resistance Dynamics (BIRD) Lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative , Salvador

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
JKJosé I. Kasprzykowski
José I. Kasprzykowski
KFKiyoshi Fukutani
Kiyoshi Fukutani
HFHelton Fabio
Helton Fabio
EFEduardo R. Fukutani
Eduardo R. Fukutani
LCLarissa C. Costa
Larissa C. Costa
AQArtur T.L. Queiroz
Artur T.L. Queiroz
There is currently no system to track the emergence of zika virus (ZIKV) subtypes. We developed a surveillance system able to retrieve sequence submissions and further classify distinct ZIKV genotypes in the world. This approach was able to detect a new occurrence of ZIKV from African lineage in Brazil in 2019.

6 December 2024 in Science Immunology
Verified
Journal Article
Closed access
PBPaul J. Baker
Paul J. Baker
ABAndrea C. Bohrer
Andrea C. Bohrer
ECEhydel Castro
Ehydel Castro
EAEduardo P. Amaral
Eduardo P. Amaral
MSMaryonne Snow-Smith
Maryonne Snow-Smith
KMKatrin D. Mayer-Barber
Katrin D. Mayer-Barber
Severity of COVID-19 is affected by multiple factors; however, it is not understood how the inflammatory milieu of the lung at the time of SARS-CoV-2 exposure affects the control of viral replication. Here, we demonstrate that immune events in the mouse lung closely preceding SARS-CoV-2 infection affect viral control and identify innate immune pathways that limit viral replication. Pulmonary inflammatory stimuli including resolved, antecedent respiratory infections with Staphylococcus aureus or influenza, ongoing pulmonary Mycobacterium tuberculosis infection, ovalbumin/alum-induced asthma, or airway administration of TLR ligands and recombinant cytokines all establish an antiviral state in the lung that restricts SARS-CoV-2 replication. In addition to antiviral type I interferons, TNFα and IL-1 potently precondition the lung for enhanced viral control. Our work shows that SARS-CoV-2 may benefit from an immunologically quiescent lung microenvironment and suggests that heterogeneity in pulmonary inflammation preceding SARS-CoV-2 exposure may contribute to variability in disease outcomes.

7 September 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
BNBetânia M F Nogueira
Betânia M F Nogueira
CVCaian Vinhaes
Caian Vinhaes
FRFrancys A Rangel
Francys A Rangel
EFEduardo R Fukutani
Eduardo R Fukutani
ENEuclimeire S Neves
Euclimeire S Neves
AQArtur T. L. Queiroz
Artur T. L. Queiroz
Background: Tuberculosis (TB) remains the leading cause of death among people with human immunodeficiency virus (HIV), yet the immunological mechanisms underlying early mortality are incompletely defined. Methods: In this prospective cohort, 152 adults hospitalized with HIV-associated TB in Bahia, Brazil, had clinical/laboratory data and plasma cytokines measured at admission and day 7. Participants were followed for 100 days; deaths were classified as early (≤14 days) or late (15–100 days). We used clustering, canonical discriminant analysis, bootstrapped correlation networks, and multivariable logistic regression. Results: Twenty-eight participants (18.4%) died: 13 early and 15 late. Early deaths had poorer functional status, greater organ dysfunction, less frequent early antiretroviral initiation, and biochemical evidence of intense systemic inflammation and coagulopathy. Unsupervised clustering did not clearly segregate outcomes, but early deaths displayed higher innate/chemotactic mediators and persistently dense, hyperconnected cytokine networks at baseline and day 7. Mortality was associated with higher day-7 Tumor Necrosis Factor (TNF)-α, interleukin (IL)–6, and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and lower day-7 IL-2, as well as higher baseline IL-1ra and lower baseline TNF-β and IL-5; baseline international normalized ratio was the only biochemical predictor. Conclusions: Early mortality in this Brazilian cohort was characterized by a dysregulated, hyperconnected inflammatory state consistent with sepsis-like hyperinflammation, supporting immune-informed risk stratification and carefully designed host-directed studies.